Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
160 participants
INTERVENTIONAL
2014-05-31
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII
NCT02093845
SORT OUT X - Combo Stent Versus ORSIRO Stent
NCT03216733
The SORT OUT IX STEMI OCT Trial
NCT02915107
Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT
NCT01405287
Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent
NCT03952273
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SYNERGY drug eluting stent
Everolimus eluting bioresorbable polymer stent
Everolimus eluting bioresorbable polymer stent
Biomatrix NeoFlex drug eluting stent
Biolimus eluting bioresorbable polymer stent
Biolimus eluting bioresorbable polymer stent
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Everolimus eluting bioresorbable polymer stent
Biolimus eluting bioresorbable polymer stent
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Do not wish to participate
* Unable to provide written informed consent
* Domicile outside Denmark
* Do not speak Danish
* Inclusion in the SORT-OUT VIII study
* Inclusion in other stent studies
* Expected survival \<1 year
* Allergy to aspirin, clopidogrel, prasugrel or ticagrelor
* Hypersensitivity to everolimus or biolimus
* The operator wishes to use other DES
* Reduced renal function; creatinine\> 120 mmol / L
* Only bare metal stent (BMS) implantation
* Only plain old balloon angioplasty (POBA)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aarhus University Hospital Skejby
OTHER
Biosensors International
OTHER
Boston Scientific Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Evald Hoej Christiansen
MD, phd
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Evald H Christiansen, MD
Role: PRINCIPAL_INVESTIGATOR
Aarhus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital, Skejby
Aarhus, , Denmark
Odense University Hospital
Odense, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-10-72-125-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.